Application Scenarios
ARA-290 is currently in the clinical research stage, with primary research focused on the following areas:
Neuropathic pain and nerve repair. The most representative human data comes from Phase II clinical trials involving sarcoidosis-associated small fiber neuropathy (SFN) and type 2 diabetes-associated peripheral neuropathy. Studies show that ARA-290 improves neuropathic pain scores and increases corneal nerve fiber density-the latter being a structural marker of nerve regeneration-suggesting potential for disease modification rather than mere symptom relief.
Metabolic regulation support. In Phase II trials involving patients with type 2 diabetes, ARA-290 demonstrated signals indicating improvements in HbA1c levels, triglycerides, and the cholesterol/HDL ratio.
Systemic anti-inflammatory and tissue-protective effects. Preclinical studies suggest organ-protective effects in models of myocardial ischemia, hemorrhagic shock, and atherosclerosis; the underlying mechanisms involve inhibiting the release of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and the activation of the NF-κB pathway.
Benefits in Bodybuilding
It is important to note that the use of ARA-290 in bodybuilding constitutes an exploratory, off-label application; the rationale is based primarily on mechanistic inferences and early human data rather than large-scale clinical trials involving athletic populations.
Mechanistically, the potential value of ARA-290 for individuals engaged in high-intensity training is evident in several areas:
Selective anti-inflammatory action without blocking anabolic signals. Acute, training-induced inflammation is a necessary signal for muscle adaptation and hypertrophy. Through its IRR-mediated, targeted anti-inflammatory action, ARA-290 inhibits excessive or pathological inflammation rather than broadly suppressing the normal post-training inflammatory repair signals. This characteristic of "gentle modulation" distinguishes it from potent immunosuppressants and, theoretically, better supports the muscle repair and supercompensation cycle in long-term trainees.
Regulation of inflammation at nerve endings and pain management. High-intensity training is often accompanied by mechanical stimulation of nerve endings and inflammation. In models of sciatic nerve injury, ARA-290 inhibits NLRP3 inflammasome activation in Schwann cells and microglial activation in the spinal cord, providing sustained relief from mechanical and cold allodynia while supporting nerve repair.
Tissue protection and recovery support. The localized upregulation of IRR in response to injury and stress ensures that ARA-290 acts in an injury-targeted manner, concentrating its anti-apoptotic and pro-repair effects in areas where training-induced micro-damage occurs (such as muscles, tendons, and nerve endings).
Well-defined safety profile. As a candidate drug that has undergone standardized toxicological assessment and human clinical trials, ARA-290's known adverse reactions are primarily limited to injection-site reactions, occasional headaches, or mild flu-like symptoms; no significant signals regarding erythropoiesis or thrombotic risk have been observed at therapeutic doses.
Storage and Usage Instructions
Storage conditions (lyophilized powder). For long-term storage, keep at -20°C in a dry, dark environment, where it remains stable for several years; short-term storage at 2–8°C is permissible. Immediate freezing upon receipt is recommended to avoid repeated exposure to room temperature.
Reconstitution procedure. Allow the vial of lyophilized powder to equilibrate to room temperature before reconstitution to prevent condensation from entering upon opening. Sterile water for injection or phosphate-buffered saline (PBS) is recommended. Slowly add the solvent along the vial wall and gently swirl or roll to dissolve; vigorous vortexing or shaking must be avoided to prevent aggregation. The reconstituted solution should be clear and free of visible particles.
Storage after reconstitution. Aliquot the solution into single-use portions immediately after reconstitution and store at -20°C or -80°C; strictly avoid repeated freeze-thaw cycles. In research settings, a sodium phosphate buffer (pH 6.5) containing 1% sucrose and 4% mannitol may also be used as a stabilizing vehicle.
Why Choose Us?
As a primary manufacturer deeply rooted in the peptide industry, we fully understand the critical importance of raw material quality for scientific research and product development. Choose us and benefit from:
Direct Factory Supply: We operate professional peptide synthesis lines, maintaining full control from raw materials to finished products. By eliminating middlemen, we offer highly competitive prices.
Consistent Quality: We utilize advanced synthesis and purification equipment to ensure every batch of ARA-290 exceeds 98% purity (verified by HPLC) with minimal batch-to-batch variation.
Strong Supply Capacity: Backed by a mature production management system, we offer stable, large-scale supply capabilities. We can meet deadlines for everything from milligram-scale R&D needs to kilogram-scale production requirements.
Professional After-Sales Support: We provide comprehensive technical documentation (COA, MS, etc.) and a professional technical team to answer questions regarding storage, dissolution, and usage, ensuring the success of your project.
FAQ
Q: Where are you located?
A: Our products originate from Shenzhen, China.
Q: What is the minimum order quantity (MOQ)?
A: The minimum order quantity is 10 bottles/sets.
Q: How soon do you ship?
A: Orders for in-stock items are shipped within 24 hours.
Q: What purity levels do you offer?
A: Standard purity is 99%.
Q: Which shipping carriers do you use?
A: Options include FedEx, DHL, UPS, and postal services.
Q: How long does shipping take?
A: Approximately 10–15 days.
Q: Can you provide COA and HPLC test reports?
A: Yes; all products undergo professional testing before shipment.
Q: Do you offer OEM/private labeling services?
A: Yes, OEM services are available, subject to minimum order quantity requirements.
Q: How do you handle after-sales issues?
A: If a quality issue caused by our production is confirmed after delivery, we offer free replacements or refunds. We are committed to a pragmatic and responsible service approach, actively addressing and resolving issues without evasion, fully protecting our customers' interests.
Q: What payment methods do you accept?
A: We accept bank transfers, Bitcoin, TransferWise, and Xoom.
Hot Tags: ara-290 10mg/vial is a potent anti-inflammatory and immunomodulatory agent. cas: 1208243-50-8, China ara-290 10mg/vial is a potent anti-inflammatory and immunomodulatory agent. cas: 1208243-50-8 manufacturers, suppliers, factory
